BioCentury | Nov 22, 2010
Company News

Exiqon, Molecular Response deal

...Exiqon's Oncotech Inc. CLIA-certified lab. Further terms were not disclosed. Exiqon announced plans to liquidate the Oncotech...
BioCentury | Jun 14, 2010
Company News

Exiqon pharmacogenetics news

...Exiqon plans to cease operations at its Tustin, Calif., CLIA-certified lab Oncotech Inc. and liquidate the assets...
...Oncotech in 2007 to accelerate R&D and establish commercial operations for the company's miRNA-based diagnostics. Oncotech...
BioCentury | Dec 21, 2009
Company News

Exiqon pharmacogenetics news

...diagnostics R&D in Denmark and divest its Tustin, Calif., CLIA-certified lab Oncotech Inc. The company acquired Oncotech...
BioCentury | Sep 7, 2009
Company News

Exiqon sales and marketing update

...of non-small cell lung cancer (NSCLC) patients to anti-EGFR treatment. The diagnostics unit was formerly Oncotech Inc....
BioCentury | Mar 10, 2008
Company News

Exiqon, Oncotech deal

...Exiqon completed the previously announced acquisition of Oncotech for 5.6 million shares valued at DKK208.1 million...
...about DKK225.7 million ($44.9 million) (see BioCentury, Dec. 3, 2007). Exiqon A/S (CSE:EXQ), Copenhagen, Denmark Oncotech Inc....
BioCentury | Mar 10, 2008
Company News

Exiqon board of directors update

...A/S (CSE:EXQ), Copenhagen, Denmarks Business: Supply/Service Appointed: Frank Kiesner, formerly CEO of newly acquired subsidiary Oncotech Inc. WIR...
BioCentury | Dec 3, 2007
Company News

Exiqon, Oncotech, Merck deal

...EXQ will acquire Oncotech for 6.2 million shares valued at DKK225.7 million ($44.9 million) based on...
...on EXQ's close of DKK36.40 on Nov. 26, the day before the deal was announced. Oncotech...
...the company. EXQ said the acquisition will allow it to enter the molecular diagnostics market. Oncotech's...
BioCentury | Dec 3, 2001
Company News

Oncotech scientific advisory board update

Oncotech Inc., Tustin, Calif. Business: Cancer Appointed: Dennis Kibler, professor of information and computer science at the University of California at Irvine WIR Staff cancer...
BioCentury | Aug 28, 2000
Company News

Beckman Coulter, Oncotech deal

...cancers. BEC will contribute its automated sample preparation, DNA/RNA hybridization, immunochemistry and flow cytometry, and Oncotech...
...clinical data to develop genetic tests and assay formats. Beckman Coulter Inc. (BEC), Fullerton, Calif. Oncotech Inc....
BioCentury | Aug 22, 2000
Company News

Beckman Coulter and Oncotech to develop cancer diagnostics

...cancers. BEC will contribute its automated sample preparation, DNA/RNA hybridization, immunochemistry and flow cytometry and Oncotech...
Items per page:
1 - 10 of 11
BioCentury | Nov 22, 2010
Company News

Exiqon, Molecular Response deal

...Exiqon's Oncotech Inc. CLIA-certified lab. Further terms were not disclosed. Exiqon announced plans to liquidate the Oncotech...
BioCentury | Jun 14, 2010
Company News

Exiqon pharmacogenetics news

...Exiqon plans to cease operations at its Tustin, Calif., CLIA-certified lab Oncotech Inc. and liquidate the assets...
...Oncotech in 2007 to accelerate R&D and establish commercial operations for the company's miRNA-based diagnostics. Oncotech...
BioCentury | Dec 21, 2009
Company News

Exiqon pharmacogenetics news

...diagnostics R&D in Denmark and divest its Tustin, Calif., CLIA-certified lab Oncotech Inc. The company acquired Oncotech...
BioCentury | Sep 7, 2009
Company News

Exiqon sales and marketing update

...of non-small cell lung cancer (NSCLC) patients to anti-EGFR treatment. The diagnostics unit was formerly Oncotech Inc....
BioCentury | Mar 10, 2008
Company News

Exiqon, Oncotech deal

...Exiqon completed the previously announced acquisition of Oncotech for 5.6 million shares valued at DKK208.1 million...
...about DKK225.7 million ($44.9 million) (see BioCentury, Dec. 3, 2007). Exiqon A/S (CSE:EXQ), Copenhagen, Denmark Oncotech Inc....
BioCentury | Mar 10, 2008
Company News

Exiqon board of directors update

...A/S (CSE:EXQ), Copenhagen, Denmarks Business: Supply/Service Appointed: Frank Kiesner, formerly CEO of newly acquired subsidiary Oncotech Inc. WIR...
BioCentury | Dec 3, 2007
Company News

Exiqon, Oncotech, Merck deal

...EXQ will acquire Oncotech for 6.2 million shares valued at DKK225.7 million ($44.9 million) based on...
...on EXQ's close of DKK36.40 on Nov. 26, the day before the deal was announced. Oncotech...
...the company. EXQ said the acquisition will allow it to enter the molecular diagnostics market. Oncotech's...
BioCentury | Dec 3, 2001
Company News

Oncotech scientific advisory board update

Oncotech Inc., Tustin, Calif. Business: Cancer Appointed: Dennis Kibler, professor of information and computer science at the University of California at Irvine WIR Staff cancer...
BioCentury | Aug 28, 2000
Company News

Beckman Coulter, Oncotech deal

...cancers. BEC will contribute its automated sample preparation, DNA/RNA hybridization, immunochemistry and flow cytometry, and Oncotech...
...clinical data to develop genetic tests and assay formats. Beckman Coulter Inc. (BEC), Fullerton, Calif. Oncotech Inc....
BioCentury | Aug 22, 2000
Company News

Beckman Coulter and Oncotech to develop cancer diagnostics

...cancers. BEC will contribute its automated sample preparation, DNA/RNA hybridization, immunochemistry and flow cytometry and Oncotech...
Items per page:
1 - 10 of 11